regulatory
confidence high
sentiment negative
materiality 0.60
ClearSign Technologies Corp (CLIR): Nasdaq/NYSE listing notice — ClearSign receives Nasdaq noncompliance notice over board independence after director resignation
ClearSign Technologies Corp
- ClearSign received Nasdaq notice on Nov 24, 2023, for noncompliance with board independence rules (Rules 5605(b)(1) and 5605(c)(2)(A)).
- Board lacks majority independent directors; audit committee has only two independent directors (needs three).
- Nasdaq granted cure period until next annual shareholder meeting or Nov 11, 2024; if meeting before May 7, 2024, cure by May 7, 2024.
- Notice has no immediate effect on listing of common stock (CLIR) on Nasdaq.